Paediatric asthma management in developing countries

Paediatric Respiratory Reviews

Volumn 3, Issue 4, 2002, Pages 285-291

  Fischer, Gilberto Bueno ^a   Camargos, Paulo Augusto Moreira ^b  

^a Fundacao Faculdade Federal Ciencias   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Action plan; Asthma; Developing countries; Mortality; Prevalence

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANTIASTHMATIC AGENT; ANTITUSSIVE AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; EPHEDRINE; SALBUTAMOL; STEROID; THEOPHYLLINE;

ADOLESCENT; ASTHMA; CHILD; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DEVELOPING COUNTRY; DRUG INDUSTRY; HEALTH CARE; HEALTH CARE QUALITY; HUMAN; LOWEST INCOME GROUP; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT PLANNING; AGE; STATISTICS;

AGE FACTORS; ASTHMA; CHILD; DEVELOPING COUNTRIES; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES;

EID: 0036886356     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(02)00272-5     Document Type: Review

References (37)

1. Anonymous. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225-1232.
2. Anonymous. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12: 315-335.
3. Camargos PAM, Castro RM, Feldman JS. Prevalencia de síntomas relacionados con el asma en escolares de Campos Gerais (MG), Brasil. Rev Panam Salud Publica 1999; 6: 8-15 (In Spanish).
4. Smyth RL. Asthma: a major pediatric health issue. Respir Res 2002; 3(supplement 1): S3-S7.
5. Beasley CRW, Pearce NE, Crane J. Worldwide trends in asthma mortality during the twentieth century. In: Sheffer AL (ed.). Fatal Asthma. New York: Marcel Dekker, 1998; pp. 13-29.
6. Noronha MF, Campos HS. Hospitalizações por asma no Brasil. Pulmão RJ 2000; 9: 10-30 (In Portuguese).
7. Ordoñez GA, Phelan PD, Olinsky A, Robertson CF. Preventable factors in hospital admissions for asthma. Arch Dis Child 1998; 78: 143-147.
8. Lasmar L, Goulart E, Sakurai E, Camargos P. Fatores de risco para hospitalização de crianças e adolescentes asmáticos em Belo Horizonte, Brasil. [Risk factors for hospital admissions in children and adolescents with asthma in Belo Horizonte, Brazil]. Rev Saude Publica 2002; 36: (in press). (In Portuguese)
9. Cabral AL, Carvalho WA, Chinen M et al. Are asthma international guidelines effective for low income Brazilian children with asthma? Eur Respir J 1998; 12: 35-40.
10. Wood PR, Hidalgo HA, Prihoda TJ, Kromer ME. Hispanic children with asthma: morbidity. Pediatrics 1993; 91: 62-69.
11. Wennergren JO, Kristjánsson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol 1996; 97: 742-748.
12. Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics 2000; 105: 272-276.
13. Jónasson G, Carlsen KCL, Leegaard J et al. Trends in hospital admissions for childhood asthma in Oslo, Norway, 1980-1995. Allergy 2000; 55: 232-239.
14. Wever-Hess J, Kouwenberg JM, Duiverman EJ, Hermans J, Wever AMJ. Risk factors for exacerbations and hospital admissions in asthma of early childhood. Pediatr Pulmonol 2000; 29: 250-256.
15. Russo MJ, McConnochie KM, McBride JT, Brooks AM, Roghmann KJ. Increase in admission threshold explains stable asthma hospitalization rates. Pediatrics 1999; 104: 454-462.
16. Stromberg L. Decreasing admissions for childhood asthma to a Swedish county hospital. Acta Paediatr 1996; 85: 173-176.
17. Mocelin HT, Fischer GB, Longhi J et al. Analysis of paediatric asthma admissions in Porto Alegre, Brazil. Eur Respir J 2002; 20(Supplement 38): 1475.
18. NHLBI/WHO. Global strategy for asthma management and prevention. In: Lenfant C (ed.) Global Initiative for Asthma. Bethesda: National Institute of Health. National Heart, Lung and Blood Institute, 2002; pp.93-172.
19. Duarte M, Camargos PAM. Emprego cle medicação profilática na asma persistente. [Use of prophylatic medication in persistent asthma]. J Pediatr (Rio J) 1999; 75: 456-462 (In Portuguese, with English abstract on http://www.jped.com.br).
20. Mallol J. Childhood asthma in developing countries. Low income aspects and related matters. Allergol Immunopathol (Madr) 2000; 28: 283-286.
21. Zhong NS. Management of asthma in developing countries. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ (eds). Asthma. Philadelphia: Lippincott-Raven, 1997; pp. 1869-1882.
22. Camargos P, Jentzsch N, Mello E. Compliance to environmental allergen avoidance procedures by asthmatic children. Eur Respir J 2002; 20(Supplement 38): 330s.
23. Ait-Khaled N, Auregan G, Bencharif N et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 2000; 4: 268-271.
24. Watson JP, Lewis RA. Is asthma treatment affordable in developing countries? Thorax 1997; 52: 605-607.
25. Zar HJ, Brown G, Donson H et al. Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial. Lancet 1999; 354: 979-982.
26. Duarte MC, Camargos P. Efficacy and safety of a home-made nonvalved spacer for bronchodilator therapy in acute asthma. Acta Paediatrica 2002; 91: 909-913.
27. Child F, Davies S, Clayton S, Fryer AA, Lenney W. Inhaler devices for asthma: do we follow the guidelines? Arch Dis Child 2002; 86: 176-179.
28. Perera BJC. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. Arch Dis Childhood 1995; 72: 312-315.
29. Fischer GB, Pheula GF, Costa JT, Mocelin HT, Penna C. Characteristics of a pediatric asthma clinic of Porto Alegre, Brazil. Eur Respir J 1999; 12(supplement 29): 38s.
30. Camargos P, Fontes M, Lasmar L. Managing childhood asthma at first level public health facilities in a developing country: south meets north at Belo Horizonte, Brazil. Alergie 2001; 3(supplement 1): 99 (Abstract no. 150).
31. Haahtela T, Klaukka T. Societal and health care benefits of early use of inhaled steroids. Thorax 1998; 53: 1005-1006. (Editorial).
32. Adams RJ, Fuhlbrigge A, Finkelstein JA et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001; 107: 706-711.
33. Blais L, Suissa S, Boivin JF, Ernst P. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998; 53: 1025-1029.
34. Ait-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ 2001; 79: 971-979.
35. Rubim JA, Simal CR, Lasmar LMLBF, Camargos PAM. Deposição pulmonar de radioaerossol e desempenho clínico verificados com espaçador fabricado no Brasil. [Aerosol deposition and clinical performance verified with a spacer device made in Brazil]. J. Pediatr. (Rio J) 2000; 76: 434-442. (In Portuguese, with full English text available on http://www.jped.com.br).
36. Camargos P, Rubim J, Lasmar L. Beclomethasone diproprionate delivered through a new spacer developed in Brazil. Eur Respir J 2000; 16(supplement 31): 541s.
37. Ates NB, Esposito-Festen JE, Tiddens HAWM, van der Mark TW. Asthma therapy for young children in developing countries: in search for a cost effective pMDI-spacer combination. Am J Respir Crit Care Med 2002; 165: A190.